Idera Pharma (IDRA) Tops Q3 EPS by 2c
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Idera Pharma (NASDAQ: IDRA) reported Q3 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $323 thousand versus the consensus estimate of $122 thousand.
For earnings history and earnings-related data on Idera Pharma (IDRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AK Steel (AKS) Pares Earlier Gains, Shares Whipsaw
- II-VI, Inc. (IIVI) Tops Q2 EPS by 11c
- Verizon Communications (VZ) Misses Q4 EPS by 3c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!